Grant: Alliance Grants
Université Laval
$68,214.00
Engineering cannabis-loaded hydrogels/emulsions to treat inflammatory tissue diseases
FY 2023-24
Summary
Skin and mouth inflammations have a profound and potentially devastating impact on patients' general well-being and self-esteem. It is estimated that skin-related illnesses rank as the fourth most frequent cause of all human diseases, affecting approximately 1.9 billion people at any time (almost one-third of the world's population). In contrast, illnesses of the oral mucosa affect close to 64% of patients. For all skin diseases reported in Canada between 1990 and 2017, disability-adjusted life years increased by 8%, with significant health and economic impacts. Treatment of these inflammatory tissue diseases often involves topical and systemic therapies with some limitations, such as toxicity and other negative outcomes. Medical cannabis products could prove to be a highly promising alternative. The safe delivery of cannabis products is also a challenge. This research project aims to design a cannabis product-loaded biopolymer to deliver cannabis products to prevent and/or cure tissue inflammatory diseases. Two different natural (fibrin and gelatin) and two different synthetic (PVA and PU) polymers will be compared in terms of cannabis product loading and distribution in polymers, delivery profile to human tissues, preservation of the cannabis activities, and the control of tissue inflammation. We intend to develop an easy to produce cannabis products delivery system (DS) in collaboration with a biotech partner. This DS will be easy to use and to cover a large skin surface without adverse effect. The designed DS will be cost-effective to the users and economic benefit to the biotech partner.
Program
Alliance Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
561197-2020
Name nom
Rouabhia, Mahmoud M
Department département
Médecine dentaire, faculté de
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2020
Award amount
68214
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
200
Area of application group en
Natural resources (economic aspects)
Area of application group fr
Ressources naturelles (aspects économiques)
Area of application en
Natural resources (economic aspects)
Area of application fr
Ressources naturelles (aspects économiques)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Life sciences research related to human health and disease
Research subject en
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Application title
Engineering cannabis-loaded hydrogels/emulsions to treat inflammatory tissue diseases
Keyword
Anti-inflammatory response of cannab; cannabis products; CBD and THC; Cytokines-inflammatory mediators; Drug delivery matrix; Microbial induced inflammation; Tissue inflammation; Ultraviolet induced inflammation
Application summary
Skin and mouth inflammations have a profound and potentially devastating impact on patients' general well-being and self-esteem. It is estimated that skin-related illnesses rank as the fourth most frequent cause of all human diseases, affecting approximately 1.9 billion people at any time (almost one-third of the world's population). In contrast, illnesses of the oral mucosa affect close to 64% of patients. For all skin diseases reported in Canada between 1990 and 2017, disability-adjusted life years increased by 8%, with significant health and economic impacts. Treatment of these inflammatory tissue diseases often involves topical and systemic therapies with some limitations, such as toxicity and other negative outcomes. Medical cannabis products could prove to be a highly promising alternative. The safe delivery of cannabis products is also a challenge. This research project aims to design a cannabis product-loaded biopolymer to deliver cannabis products to prevent and/or cure tissue inflammatory diseases. Two different natural (fibrin and gelatin) and two different synthetic (PVA and PU) polymers will be compared in terms of cannabis product loading and distribution in polymers, delivery profile to human tissues, preservation of the cannabis activities, and the control of tissue inflammation. We intend to develop an easy to produce cannabis products delivery system (DS) in collaboration with a biotech partner. This DS will be easy to use and to cover a large skin surface without adverse effect. The designed DS will be cost-effective to the users and economic benefit to the biotech partner.